|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/14 | |
| A61K 31/4439 | |||
| A61P 1/04 |
| (11) | Patento numeris | 2102191 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07866107.1 |
| Europos patento paraiškos padavimo data | 2007-12-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-09-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-11-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/089137 |
| Data | 2007-12-28 |
| (87) | Numeris | WO 2008/083341 |
| Data | 2008-07-10 |
| (30) | Numeris | Data | Šalis |
| 877608 P | 2006-12-29 | US | |
| 887499 P | 2007-01-31 | US |
| (72) |
BRACKETT, John, M., US
JONAITIS, David, T., US
LAI, Wei, US
PARENT, Stephan, D., US
|
| (73) |
IL YANG PHARMACEUTICAL COMPANY, LTD.,
182-4 Hagal-dong Giheung-gu, Yongin-si, Gyeonggi-do 449-726,
KR
|
| (54) | CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE |
| CRYSTALLINE FORMS OF SOLVATED ILAPRAZOLE |